About
Skin Analytics, founded in 2012 in London, UK, is an AI tool that uses image recognition to identify skin lesions and assist in the detection of skin cancer.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 1
Founders / team· 1
Funding history
- 2025-04Series B$20M
Investors · Intrepid PartnersSource · SVTR Weekly #101
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Skin Analytics
AI tool that assists skin cancer detection by identifying skin lesions from images
Series B · $20M · 2025-04
$20M
United States
BusinessLatest roundTotal raisedDate- Evvy
At-home vaginal microbiome metagenomic sequencing tests and an accompanying prescription care platform
Series B · $59M · 2026-09
$59M - Tiny Health
At-home gut and vaginal microbiome tests, with TinyAI trained on proprietary data giving personalized health recommendations, for consumers and healthcare practitioners
Series B · $46M · 2026-09
$46M - Epitel
Wireless wearable remote EEG monitoring system (REMI) + AI seizure event detection (REMI Vigilenz)
Series B · $39M · 2026-07
$39M
China
BusinessLatest roundTotal raisedDate- 透彻未来
AI-based pathology image diagnosis services
Series A · $69M · 2024-06
$69M - SleepWell Technology Corp.
AI sleep health screening and brainwave intervention (smartphone face-scan screening + brainwave eye mask)
— - 睿心医疗
Developer of AI precision diagnosis and treatment platforms for cardiovascular and cerebrovascular disease and of vascular interventional surgical robots.
Strategic · 2026-07
—
Europe
BusinessLatest roundTotal raisedDate- Oxford Cancer Analytics
AI-based blood tests for cancer detection
Series A · $11M · 2025-01
$11M - Blue Box Biomedical
Early breast cancer screening devices using saliva samples and AI
Seed · $4M · 2025-07
$4M - Holifya
AI-driven digital obesity clinic with personalized GLP-1 weight-loss treatment management
$3M · 2026-09
$3M
Other / unspecified
BusinessLatest roundTotal raisedDate- Ibex Medical Analytics
AI-based cancer diagnostics technology
Series C · $55M · 2023-09
$55M - FluidAI Medical
AI solution for early detection of missed postoperative diagnoses
Series A · $15M · 2023-10
$15M - Nucleai
Uses AI to analyze pathology images for medical research and clinical diagnosis
Undisclosed · $14M · 2024-04
$14M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
38 Life Sciences deals in the last 24 months · 19 at a nearby stage · 1 in United Kingdom
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 12 at a nearby stage · 3 in United Kingdom
Request intro →GV
14 Life Sciences deals in the last 24 months · 9 at a nearby stage · 3 in United Kingdom
Request intro →Alumni Ventures
12 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in United Kingdom
Request intro →Accel
12 Life Sciences deals in the last 24 months · 7 at a nearby stage · 2 in United Kingdom
Request intro →Catalio Capital Management
9 Life Sciences deals in the last 24 months · 7 at a nearby stage · 1 in United Kingdom
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.